Coupang (CPNG) Form 144: sale of 75,350 shares, $2.18M value

Coupang, Inc. (CPNG) received a Form 144 notice for a proposed sale of 75,350 common shares, with an aggregate market value of $2,176,108.

Rhea-AI Filing Summary

Coupang, Inc. (CPNG) received a Form 144 notice for a proposed sale of 75,350 common shares, with an aggregate market value of $2,176,108. The filer plans to sell on or about 11/10/2025 on the NYSE through Morgan Stanley Smith Barney LLC.

The shares derive from previously exercised stock options: 12,100 shares acquired on 10/21/2020 and 63,250 on 12/13/2021, both paid in cash. The recent activity section shows a sale of 75,350 shares on 08/11/2025 for $2,093,803.20 under a Rule 10b5-1 plan.

Insights

Securities law analyst

Form 144 signals a shareholder’s planned sale; no issuer proceeds.

This notice lists a proposed resale of 75,350 Coupang common shares under Rule 144, using Morgan Stanley as broker. Rule 144 governs public resales of restricted or control securities by affiliates and others, and the filing outlines the amount, timing, and method.

The filing indicates the shares originated from stock option exercises in 2020 and 2021. It also records a prior 75,350-share sale on 08/11/2025 under a Rule 10b5-1 plan. Cash proceeds from any sale go to the selling holder, not the company.

Actual market impact depends on execution details and trading volume. Subsequent company disclosures may update activity and remaining capacity under the plan, if any.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Coupang (CPNG)’s Form 144 disclose?

A planned resale of 75,350 common shares with an aggregate market value of $2,176,108, targeting 11/10/2025 on the NYSE via Morgan Stanley.

How were the CPNG shares acquired for this Form 144?

From previously exercised stock options: 12,100 shares on 10/21/2020 and 63,250 on 12/13/2021, both paid in cash.

Does Coupang receive proceeds from this sale?

No. Proceeds from any sale under this Form 144 would go to the selling security holder, not to Coupang.

Was there recent selling activity related to CPNG?

Yes. The filing lists a sale of 75,350 shares on 08/11/2025 for $2,093,803.20 under a Rule 10b5-1 plan.

Which broker and exchange are named for the proposed CPNG sale?

Broker: Morgan Stanley Smith Barney LLC; Exchange: NYSE.

How many Coupang shares are shown as outstanding in the filing?

The table shows 1,668,844,548 shares outstanding; this is a baseline figure.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/10/2025 - 04:34 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001849248
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	COUPANG INC
SEC File Number	001-40115
Address of Issuer	720 Olive Way, Suite 600 SEATTLE WASHINGTON 98101
Phone	206-333-3839
Name of Person for Whose Account the Securities are To Be Sold	GAURAV ANAND
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	75350	2176108.00	1668844548	11/10/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/21/2020	Previously Exercised Stock Options	Issuer			12100	10/21/2020	Cash
Common	12/13/2021	Previously Exercised Stock Options	Issuer			63250	12/13/2021	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for GAURAV ANAND 720 Olive Way, Suite 600 SEATTLE WA 98101	Common	08/11/2025	75350	2093803.20

144: Remarks and Signature

Remarks	The sales of shares set forth herein are made in connection with a stock trading plan adopted on December 8, 2024 in accordance with SEC guidelines specified under Rule 10b5-1 of the Securities Exchange Act of 1934, as amended and such plan is intended to comply with Rule 10b5-1(c).
Date of Notice	11/10/2025
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	12/08/2024
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Gaurav Anand
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)